Greenland Mines Ltd. Common Stock

GRMLNASDAQUSD
0.31 USD
0.03 (8.36%)AT CLOSE (11:59 AM EDT)
0.31
0.00 (1.30%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.31
0.00 (1.30%)
🔴Market: CLOSED
Open?$0.33
High?$0.33
Low?$0.30
Prev. Close?$0.34
Volume?3.7M
Avg. Volume?3.5M
VWAP?$0.31
Rel. Volume?1.06x
Bid / Ask
Bid?$0.26 × 100
Ask?$0.35 × 100
Spread?$0.10
Midpoint?$0.31
Valuation & Ratios
Market Cap?41.2M
Shares Out?121.2M
Float?100.8M
Float %?83.2%
P/E Ratio?N/A
P/B Ratio?0.80
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A

Greenland Mines Ltd. Common Stock (GRML) trades at $0.30 per share. Technical indicators currently signal "Strong Sell". Notable factors include negative Return on Equity. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Employees
5
Market Cap
39.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2026-03-12
Address
13576 WALNUT STREET, SUITE A
OMAHA, NE 68144
Phone: (833) 931-6330
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestElevated
Short % of Float?5.04%Elevated
Short Interest?5.1M
Days to Cover?1.8
Free Float100.8M
Avg Daily Volume2.9M
Settlement Date2026-05-15
Financial Health
Current Ratio?19.74Strong
Quick Ratio?19.74Strong
Cash Ratio?18.06Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.80CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.1CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-43.1%WEAK
ROA?
S&P
3
-37.1%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$31.2M
Fundamentals ratios updated end of day